Quarterly report pursuant to Section 13 or 15(d)

Schedule of Share Option Activity (Details)

v3.21.2
Schedule of Share Option Activity (Details) - $ / shares
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]    
Number of Options, Beginning Balance 756,383 509,173
Weighted average exercise price, Beginning Balance $ 1.82 $ 1.30
Weighted average remaining contractual term, Beginning Balance 8 years 8 months 12 days 7 years 4 months 24 days
Number of Options, Granted 1,280,939 505,726
Weighted average exercise price, Granted $ 4.54 $ 2.01
Number of Options, Exercised (29,916) (59,909)
Weighted average exercise price, Exercised $ 1.24 $ 2.00
Number of Options, Forfeited (91,084) (33,756)
Weighted average exercise price, Forfeited $ 3.82 $ 2.00
Number of Options, Expired (11,204) (155,110)
Weighted average exercise price, Expired $ 1.45 $ 1.04
Number of Options, Ending Balance 2,152,838 766,124
Weighted average exercise price, Ending Balance $ 4.76 $ 1.77
Weighted average remaining contractual term, Ending Balance 8 years 9 months 18 days 7 years 9 months 18 days
Number of Options, Exercisable 612,132 345,421
Weighted average exercise price, Exercisable $ 5.73 $ 1.22
Weighted average remaining contractual term, Exercisable 7 years 6 months 6 years 10 months 24 days
Number of Options, Additional options to StemoniX option holders 191,880  
Weighted average exercise price, Additional options to StemoniX option holders $ 4.61  
Number of Options, assumed in Merger 55,840  
Weighted average exercise price, Options assumed in Merger $ 45.95